Home > Drug Search >
  • company_query: Arissa Pharma
  •   > 
Drug Filter
Category:
chemistry (11) biology (8)
Status:
Approved (2) NDA Filing (1) Phase Ⅲ (3) Phase Ⅱ (11) Phase Ⅰ (2)
Clinical Stage:
Pending (2) Active (10) Discontinued (5)
Bio-Type:
Vaccine (3) Whole antibody (5)
Indication:
Asthma (1) Bladder cancer (1) Chronic lymphocytic leukemia (CLL) (1) Diabetic macular edema (1) Urogenital cancer (1) Follicular lymphoma (1) Hepatocellular carcinoma (HCC) (1) Cystinuria (1) Hypertriglyceridemia (1) Melanoma (1) Metastatic breast cancer (1) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (1) Non-Hodgkin’s lymphoma (NHL) (1) Osteoarthritis (OA) (1) Parkinson's disease (PD) (1) Rheumatoid arthritis (RA) (2) Solid tumours (3) Tuberculosis (1) Age-related macular degeneration (AMD) (1) Pain (3) Stroke (1) Staphylococcal infection (2)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top